Twist Bioscience Corporation (TWST): Price and Financial Metrics

Twist Bioscience Corporation (TWST): $26.98

0.57 (+2.16%)

POWR Rating

Component Grades








Add TWST to Watchlist
Sign Up

Industry: Biotech




#279 of NR

in industry

TWST Price/Volume Stats

Current price $26.98 52-week high $31.51
Prev. close $26.41 52-week low $11.46
Day low $24.81 Volume 1,560,500
Day high $27.17 Avg. volume 1,182,511
50-day MA $19.74 Dividend yield N/A
200-day MA $18.62 Market Cap 1.56B

TWST Stock Price Chart Interactive Chart >

Twist Bioscience Corporation (TWST) Company Bio

Twist Bioscience Corp. develops proprietary semiconductor-based synthetic DNA manufacturing process. It produces synthetic biology tools such as oligonucleotides, genes, pathways, chassis, and genomes. The firm also produces agriculture production as well as new applications such as in vivo diagnostics, biodetection and data storage. The company was founded by William Marine Banyai, Emily Marine Leproust and Bill James Peck in 2013 and is headquartered in San Francisco, CA.

TWST Latest News Stream

Event/Time News Detail
Loading, please wait...

TWST Latest Social Stream

Loading social stream, please wait...

View Full TWST Social Stream

Latest TWST News From Around the Web

Below are the latest news stories about TWIST BIOSCIENCE CORP that investors may wish to consider to help them evaluate TWST as an investment opportunity.

Twist Bioscience launches human methylome panel

Twist Bioscience (NASDAQ:TWST) on Tuesday announced the launch of its Human Methylome Panel, a product that can advance applications in cancer metastasis, human development and functional genetics. The company said its Twist Human Methylome Panel can also be used as a discovery tool to identify methylation biomarkers that can then be...

Seeking Alpha | May 31, 2022

Read More 'TWST' Stories Here

TWST Price Returns

1-mo 59.93%
3-mo 17.41%
6-mo 45.44%
1-year 10.48%
3-year -82.27%
5-year 17.30%
YTD 13.31%
2022 -69.23%
2021 -45.23%
2020 572.81%
2019 -9.05%
2018 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!